اکنون در دسترس! پژوهش تلگرام ۲۰۲۵ — مهمترین بینشهای سال 
Pharmatalks
رفتن به کانال در Telegram
International Channel🎉 @Pharmatalks Chat group ✔️ @Pharmatalks_group Ads تبلیغات🔝 @Pharmatalkads Pharmacopoeia 📚 @USP_2024
نمایش بیشتر📈 تحلیل کانال تلگرام Pharmatalks
کانال Pharmatalks (@pharmatalks) در بخش زبانی انگلیسی بازیگری فعال است. در حال حاضر جامعه شامل 18 046 مشترک است و جایگاه 11 226 را در دسته آموزش و رتبه 2 176 را در منطقه الولايات المتحدة الأمريكية دارد.
📊 شاخصهای مخاطب و پویایی
از زمان ایجاد در невідомо، پروژه رشد سریعی داشته و 18 046 مشترک جذب کرده است.
بر اساس آخرین دادهها در تاریخ 10 ژوئن, 2026، کانال فعالیت پایداری دارد. در ۳۰ روز گذشته تغییر اعضا برابر -80 و در ۲۴ ساعت گذشته برابر -6 بوده و همچنان دسترسی گستردهای حفظ شده است.
- وضعیت تأیید: تأیید نشده
- نرخ تعامل (ER): میانگین تعامل مخاطب 15.43% است و در ۲۴ ساعت نخست پس از انتشار، محتوا معمولاً 4.64% واکنش نسبت به کل مشترکان کسب میکند.
- دسترسی پستها: هر پست به طور میانگین 2 785 بازدید دریافت میکند. در اولین روز معمولاً 838 بازدید جمعآوری میشود.
- واکنشها و تعامل: مخاطبان بهطور فعال حمایت میکنند؛ میانگین واکنش به هر پست 6 است.
- علایق موضوعی: محتوا بر موضوعات کلیدی مانند validation, pharma, pharmatalk, qualification, iso تمرکز دارد.
📝 توضیح و سیاست محتوایی
نویسنده این فضا را محل بیان دیدگاههای شخصی توصیف میکند:
“International Channel🎉 @Pharmatalks
Chat group ✔️ @Pharmatalks_group
Ads تبلیغات🔝 @Pharmatalkads
Pharmacopoeia 📚 @USP_2024”
به لطف بهروزرسانیهای پرتکرار (آخرین داده در تاریخ 11 ژوئن, 2026)، کانال همواره بهروز و دارای دسترسی بالاست. تحلیلها نشان میدهد مخاطبان بهطور فعال با محتوا تعامل دارند و آن را به نقطه اثرگذاری مهم در دسته آموزش تبدیل کردهاند.
18 046
مشترکین
-624 ساعت
-117 روز
-8030 روز
آرشیو پست ها
18 046
⚠️ Risk Management in the Pharmaceutical Industry
In pharma, risk management helps teams protect patients, ensure quality, and maintain compliance.
It also supports better decisions before small issues become major problems.
Key risk areas include:
✅ Quality risk
✅ Operational risk
✅ Compliance risk
✅ Supply chain risk
✅ Safety risk
✅ Data integrity risk
✅ Equipment and process risk
Common risk management tools include:
🔹 FMEA
🔹 HAZOP
🔹 Root Cause Analysis
🔹 Risk Matrix
🔹 Pareto Analysis
🔹 Checklists and SOPs
Strong risk management helps pharma teams:
✅ Identify risks early
✅ Prioritize high-impact issues
✅ Reduce deviations and errors
✅ Improve CAPA effectiveness
✅ Strengthen GMP compliance
✅ Support patient safety
Risk management is not just a document.
It is a proactive mindset for safer products and stronger quality systems.
Want to build stronger GMP risk management skills?
👉 Explore Pharmuni’s GMP Risk Management Principles course:
https://pharmuni.com/courses/18/gmp-risk-management-principles
18 046
Where Are the Best Biotech and Pharmaceutical Jobs in the USA? 🇺🇸💊
📍 Top States for Biotech and Pharma Careers:
✅ California – Strong biotech hubs, innovation, and research opportunities.
✅ Massachusetts – Known for biotech startups, R&D, and scientific innovation.
✅ New Jersey – Home to major pharmaceutical headquarters and regulatory roles.
✅ North Carolina – Growing opportunities in bioprocessing and manufacturing.
✅ Pennsylvania – Expanding biotech, production, and quality career options.
✅ Texas – Rising demand in clinical research and life sciences manufacturing.
Whether you are starting your career or seeking your next position, focus on the right location, build relevant skills, and explore opportunities consistently.
🚀 Ready to take the next step in your pharmaceutical career?
Explore pharma job opportunities on Pharmuni:
https://l1nq.com/eevf8pq
18 046
🔐 Key Requirements of 21 CFR Part 11 Training
In regulated pharma environments, electronic records and electronic signatures must be controlled, traceable, and reliable.
Teams should understand:
✅ When 21 CFR Part 11 applies
✅ Why computerized systems need validation
✅ How audit trails support traceability
✅ Why access control protects data integrity
✅ How electronic signatures must be managed
✅ Why SOPs and training are essential
✅ How record integrity supports inspection readiness
21 CFR Part 11 is not only an IT topic.
It connects quality, compliance, validation, documentation, and patient safety.
Want to build stronger knowledge in computerized system compliance?
👉 Explore Pharmuni’s Introduction to Computer Systems Validation (CSV) course:
https://shorturl.at/EyAuD
18 046
🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys
18 046
🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys
18 046
⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification
18 046
⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification
18 046
Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️
The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed:
Watch NOW PHARMATALKS FULL Podcast HERE
https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo
1. Q1 Series (Stability Testing) 🧪
Focuses on stability testing protocols to determine shelf life and storage conditions.
2. Q2(R1) (Analytical Validation) 🔬
Provides guidance on validating analytical procedures to ensure accuracy and reliability.
3. Q3A/B (Impurities) 💊
Addresses impurities in drug substances and products, emphasizing control strategies.
4. Q4B (Pharmacopoeial Harmonization) 📚
Facilitates harmonization of monographs across different pharmacopoeias.
5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬
Covers quality considerations specific to biotech and biological products.
18 046
Repost from Pharmatalks
SOP for Self Inspection Procedure
👇👇👇
Join the #Pharmatalks community and gain access to over 2,000 documents on the #pharmaceuticalIndustry! 📚💊 Don't miss out, click the link below to join now!
👇👇👇👇👇👇👇
https://t.me/addlist/YMYs20TiWdY1MTY0
18 046
Repost from Pharmatalks
Summary of ICH Quality Guidelines
👇👇👇
Join the #Pharmatalks community and gain access to over 2,000 documents on the #pharmaceuticalIndustry! 📚💊 Don't miss out, click the link below to join now!
👇👇👇👇👇👇👇
https://t.me/addlist/YMYs20TiWdY1MTY0
18 046
Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️
The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed:
Watch NOW PHARMATALKS FULL Podcast HERE
https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo
1. Q1 Series (Stability Testing) 🧪
Focuses on stability testing protocols to determine shelf life and storage conditions.
2. Q2(R1) (Analytical Validation) 🔬
Provides guidance on validating analytical procedures to ensure accuracy and reliability.
3. Q3A/B (Impurities) 💊
Addresses impurities in drug substances and products, emphasizing control strategies.
4. Q4B (Pharmacopoeial Harmonization) 📚
Facilitates harmonization of monographs across different pharmacopoeias.
5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬
Covers quality considerations specific to biotech and biological products.
18 046
Repost from Pharmatalks
Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️
The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed:
Watch NOW PHARMATALKS FULL Podcast HERE
https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo
1. Q1 Series (Stability Testing) 🧪
Focuses on stability testing protocols to determine shelf life and storage conditions.
2. Q2(R1) (Analytical Validation) 🔬
Provides guidance on validating analytical procedures to ensure accuracy and reliability.
3. Q3A/B (Impurities) 💊
Addresses impurities in drug substances and products, emphasizing control strategies.
4. Q4B (Pharmacopoeial Harmonization) 📚
Facilitates harmonization of monographs across different pharmacopoeias.
5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬
Covers quality considerations specific to biotech and biological products.
18 046
🔟 Top 10 Pillars of Chromatography
📽️ Watch the Full Video Now 👉https://www.youtube.com/watch?v=OdjjLjUcW8I
⚗️ Stationary Phase
💧 Mobile Phase
🧪 Sample Preparation
⏱️ Flow Rate Control
🌡️ Temperature Control
🎯 Detector Selection
📊 System Suitability
🧠 Method Development
🛡️ Data Integrity & Compliance
🔧 Maintenance & Calibration
18 046
🔟 Top 10 Pillars of Chromatography
⚗️ Stationary Phase
💧 Mobile Phase
🧪 Sample Preparation
⏱️ Flow Rate Control
🌡️ Temperature Control
🎯 Detector Selection
📊 System Suitability
🧠 Method Development
🛡️ Data Integrity & Compliance
🔧 Maintenance & Calibration
18 046
🔬 Key Aspects of Bioburden Testing:
📺
👉 WATCH OUR COMPLETE GUIDE TO BIOBURDEN TESTING!
1. Purpose: Determines the microbial load before terminal sterilization
2. When Performed: On raw materials, in-process samples, and finished products
3. Methods Used: Membrane filtration, pour plate, spread plate, and most probable number (MPN)
4. Microorganisms Detected: Bacteria, yeast, mold, and sometimes specific indicator organisms
5. Regulatory Requirements: Mandated by FDA, EMA, and other global health authorities
6. Critical Limits: Varies by product type and intended use
7. Validation: Methods must be validated for each product type
8. Environmental Monitoring: Linked to cleanroom classification and monitoring
9. Trend Analysis: Data used for continuous improvement
10. Sterility Assurance: Directly impacts sterilization validation (D-value calculations)
18 046
⏱️ Steps for Handling OOS Results
⛨ Phase 1: Laboratory Investigation
✔ Immediate actions
✔ Analyst’s self-check
✔ Instrument review
✔ Sample preparation verification
✔ Chromatograms review (integration errors, system suitability)
⛨ Phase 1 Outcome
Invalid result → assign root cause, re-test allowed.
No assignable cause → move to Full-Scale Investigation.
⛨ Phase 2: Full-Scale Investigation (QA + Production)
✔ Review of manufacturing batch records
✔ Review of deviations, environment, equipment
✔ Evaluation of analyst training
✔ Hypothesis testing (additional testing if justified)
✔ Impact assessment on other batches
